These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22950955)

  • 61. Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndrome.
    Jacob S; Henriksen EJ
    J Clin Hypertens (Greenwich); 2004 Dec; 6(12):690-6; quiz 697. PubMed ID: 15599117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
    Ukkola O
    Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Managing cardiovascular risk in patients with metabolic syndrome.
    Bassand JP
    Clin Cornerstone; 2006; 8 Suppl 1():S7-14. PubMed ID: 16903164
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of Chinese prescription Kangen-karyu for patient with metabolic syndrome.
    Kitazawa T; Park CH; Hiratani K; Choi JS; Yokozawa T
    Drug Discov Ther; 2020 Mar; 14(1):54-57. PubMed ID: 32115440
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
    Chen J; Townsend RR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 69. [From the metabolic syndrome to the concept of global cardiometabolic risk].
    Nádas J; Jermendy G
    Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications.
    Eschwège E
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S19-27. PubMed ID: 14502097
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic syndrome: controversial but useful.
    Stolar M
    Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.
    Makaryus AN; Akhrass P; McFarlane SI
    Curr Diab Rep; 2009 Jun; 9(3):229-37. PubMed ID: 19490825
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Addressing the insulin resistance syndrome: a role for the thiazolidinediones.
    Zimmet P
    Trends Cardiovasc Med; 2002 Nov; 12(8):354-62. PubMed ID: 12536122
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension.
    Cerezo C; Segura J; Praga M; Ruilope LM
    Curr Hypertens Rep; 2013 Jun; 15(3):196-203. PubMed ID: 23519746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome.
    Florentin M; Elisaf MS; Mikhailidis DP; Liberopoulos EN
    Curr Pharm Des; 2009; 15(29):3446-62. PubMed ID: 19860690
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [How to treat dyslipidemia in patients with metabolic syndrome].
    Soška V
    Vnitr Lek; 2015; 61(7-8):721-4. PubMed ID: 26375703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 78. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen mL; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():S1-113. PubMed ID: 17726407
    [No Abstract]   [Full Text] [Related]  

  • 79. Prehypertension and the cardiometabolic syndrome: is there any value in pharmacologic intervention?
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):146-8. PubMed ID: 17679828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Managing multiple cardiovascular risk factors: state of the science.
    Levine JH
    J Clin Hypertens (Greenwich); 2006 Oct; 8(10 Suppl 3):12-22. PubMed ID: 17028479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.